Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Atrix acquires ViroTex and expands drug delivery technology base

Dec. 4, 1998

Isis sublicenses technology for designing improved antisense drugs

Dec. 2, 1998

Novel injectable drug delivery technology in-licensed by Medi-Ject

Dec. 2, 1998

Jenner Biotherapies receives patent on improved vaccine formulation

Dec. 1, 1998

Transkaryotic Therapies extends agreement with PolyMASC to include second drug candidate

Nov. 30, 1998

Inex receives patent protection for vital component of TCS delivery system

Nov. 30, 1998

Cell Genesys describes improved vectors for gene therapy

Nov. 27, 1998

Pharmacopeia achieves milestone in collaboration with Schering-Plough

Nov. 26, 1998

GeneMedicine expands collaboration with Merck for GeneSwitch technology

Nov. 25, 1998

AVI BioPharma presents advantages of CytoPorter drug delivery engine

Nov. 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...